Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | MMP3 | P08254 | 5/20 | 0.59 |
| ▸ | MMP2 | P08253 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | RARB | P10826 | 3/20 | 0.50 |
| ▸ | HRH2 | P25021 | 2/20 | 0.49 |
| ▸ | HRH1 | P35367 | 2/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1874571 | 0.95 | HDAC1 (0.56) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| Phenol SCHEMBL1877890 | 0.90 | MMP2 (0.52) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL29321625 | 0.84 | ALDH1A1 (0.49) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL29316111 | 0.84 | ALDH1A1 (0.49) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL21078349 | 0.83 | HTT (0.55) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL12676172 | 0.83 | HDAC1 (0.50) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL8621621 | 0.83 | NPC1 (0.63) | HDAC1HDAC2MMP3ALDH1A1MAPT | |
| SCHEMBL10054731 | 0.83 | MMP2 (0.52) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL2993045 | 0.83 | HRH2 (0.56) | HDAC1HDAC2MMP3MMP2ALDH1A1 | |
| SCHEMBL3434932 | 0.83 | NPC1 (0.63) | HDAC1HDAC2MMP3ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11781070-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-10 | — | — | US | disclosed |
| US-11781070-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11781070-B2 | Mesogen compounds | MDN1, LSG1, MNS1 | HDAC1 3686/4885HDAC2 4337/4885MMP3 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.